CORONA VIRUS

CORONA VIRUS
JAI NARAIN VYAS UNIVERSITY, JODHPUR
ASSISTANT PROFESSOR:- ASHWIN SINGH
CHOUHAN
DEPARTMENT:- PHARMACOLOGY
E-mail:- anshukavya1993@gmail.com

JNVU PHARMACY, JODHPUR
CORONAVIRUS, any virus belonging to the family
Coronaviridae.
Coronaviruses have enveloped virions (virus particles)
that measure approximately 120 nm (1 nm =
10−9 metre) in diameter.
Club-shaped glycoprotein spikes in the envelope give
the viruses a crownlike, or coronal, appearance.
The nucleocapsid, made up of a protein shell known as
a capsid and containing the viral nucleic acids, is helical
or tubular.
The coronavirus genome consists of a single strand of
positive-sense RNA (ribonucleic acid).

Coronaviridae is generally considered to contain two
genera, Corona virus and Toro virus, which differ in
nucleocapsid morphology, the former being helical and the
latter being tubular.
Corona viruses are important agents of gastrointestinal
disease in humans, poultry, and bovines.
In humans, a species known as SARS corona virus (or Severe
acute respiratory syndrome corona virus) causes a
highly contagious respiratory disease that is characterized by
symptoms of fever, cough, and muscle ache, often with
progressive difficulty in breathing.
The virus emerged in humans in 2002; it likely jumped to
humans from an animal reservoir, believed to be
horseshoe bats.
The ability of SARS corona virus to jump to humans
undoubtedly required genetic changes in the virus. These
changes are suspected to have occurred in the palm civet,
since the SARS virus present in horseshoe bats is unable to
infect humans directly (see SARS).

In 2012 another corona virus capable of causing a
severe acute respiratory illness later known as Middle
East respiratory syndrome (MERS) was discovered in
humans.
The first case was found in Saudi Arabia, and others
were reported within the following year in France,
Germany, Jordan, Qatar, Tunisia, the United Arab
Emirates, and the United Kingdom. All confirmed cases
were directly or indirectly linked to the Middle East. Of all
confirmed cases documented by 2019, roughly one-third
had ended in death.
The novel MERS corona virus was similar to other
corona viruses known to have originated in bats and was
thought to be passed from bats to other animals before
being transmitted to humans. Camels were identified as
one possible reservoir for the MERS virus.

In late 2019 a virus apparently closely related to SARS
corona virus emerged in Wuhan, China. The virus, later
named severe acute respiratory syndrome corona virus 2
(SARS-CoV-2), caused an illness known as COVID-19,
which was similar to SARS and was being characterized
primarily by fever and respiratory symptoms.
The virus was likewise highly contagious. By early 2020
it had spread throughout regions of China and had
reached the United States and Europe, having been
carried by travelers from affected regions.
In March the World Health Organization declared the
outbreak a pandemic, and travel to, from, and within
many countries was severely restricted in an effort to
control its spread.
In many areas, schools and many businesses closed,
and stay-at-home guidelines were implemented, which
strongly encouraged people not to leave their places of
residence.

COVID-19
In 2019, the Centers for Disease Control and Prevention
(CDC) started monitoring the outbreak of a new
coronavirus, SARS-CoV-2, which causes COVID-19.
Authorities first identified the virus in Wuhan, China.
Since then, the virus has spread to nearly every
country, leading the World Health Organization (WHO) to
declare a pandemic.
The new coronavirus has been responsible
for millions of infections globally, causing hundreds of
thousands of deaths. The United States has seen the
highest number of these deaths.
The first people with COVID-19 had links to an animal
and seafood market. This suggests that animals initially
transmitted the virus to humans. Then, people with no
connections to the market developed the disease,
confirming that humans can pass the virus to each other.

Most people who get COVID-19 will have a mild form of the
disease. According to the WHO, around 80% of people who get
COVID-19 will recover without needing hospitalization.
The remaining 20% become seriously ill and develop
difficulty breathing.
Some groups are more at risk of severe disease, including
older adults and people with underlying medical concerns,
including high blood pressure, heart and lung problems,
diabetes, and cancer.
The mortality rate varies between countries. In the U.S., the
death rate is around 6%.
According to the CDC, children are not at higher risk of
COVID-19 than adults.
Pregnant women appear to have the same risk of COVID-19
as other adults. However, during pregnancy, women have a
higher risk of severe illness from viruses that are similar to
SARS-CoV-2 and influenza.
The CDC also recommend that infants born to women with
suspected or confirmed COVID-19 are put into isolation.

SYMPTOMS OF COVID-19
According to the CDC, people may start to experience
symptoms 2–14 days after exposure to the virus.
Symptoms may include:
a fever
chills
a cough
shortness of breath or difficulty breathing
sore throat
congestion or a runny nose
fatigue
headache
muscle pain
new loss of taste or smell
nausea or vomiting
diarrhea

According to the CDC, the following groups have a
higher risk of developing serious illness from COVID-19:
people aged 65 years or older.
people living in nursing homes or care facilities.
people of any age who have serious underlying medical
conditions, including chronic lung disease, serious heart
conditions, severe obesity, a compromised immune
system, or diabetes.
The CDC note that although there have been reports of
complications in young children, these are rare.
COVID-19 most commonly produces mild symptoms in
children.

Types
Coronaviruses belong to the subfamily Coronavirinae in
the family Coronaviridae.
Different types of coronavirus vary, in terms of the
severity of disease that they cause and how far they
spread.
Doctors currently recognize seven types of coronavirus
that can infect humans.
Common types include:
229E (alpha coronavirus)
NL63 (alpha coronavirus)
OC43 (beta coronavirus)
HKU1 (beta coronavirus)
Rarer strains that cause more severe illnesses include
MERS-CoV, which causes the disease MERS, and SARS-
CoV, the virus responsible for SARS.
In 2019, a new strain, called SARS-CoV-2, started
circulating, causing the disease COVID-19.

TRANSMISSION
The CDC recommend that all people wear cloth face
masks in public places where it is difficult to maintain a
6-foot (2-meter) distance from others.
This will help slow the spread of the virus from
asymptomatic people and people who do not know that
they have contracted it.
People should wear cloth face masks while continuing to
practice physical distancing. Instructions for making
masks at home are available here.
Note: It is critical that surgical masks and N95
respirators are reserved for healthcare workers.
Researchers believe that the viruses transmit via fluids
in the respiratory system, such as mucus.

For example, a coronavirus can spread when a person:
coughs or sneezes without covering their mouth,
dispersing droplets into the air.
touches someone who has the infection.
touches a surface that has the virus, then touches their
own nose, eyes, or mouth.

Some animal coronaviruses may spread to humans
through contact with feces, though it is unclear whether
human coronaviruses can spread in the same way.
Coronaviruses will infect most people at some point.
To prevent transmission, people with symptoms should
stay at home, rest, and avoid coming into close contact
with other people.
Covering the mouth and nose with a tissue or
handkerchief while coughing or sneezing can also help
prevent transmission. It is important to dispose of used
tissues right away and maintain proper hygiene around
the home.

SARS
SARS is a contagious disease that develops from
infection with the SARS-CoV coronavirus. In many cases,
it leads to a life threatening form of pneumonia.
In November 2002, the virus started circulating in the
Guangdong province of southern China, eventually
reaching Hong Kong. From there, it rapidly spread,
causing infections in more than 24 countries.
Experts no longer consider SARS a risk. Since 2003,
there have only been a few cases due to laboratory
accidents or, possibly, transmission from animals.
SARS-CoV affects both the upper and lower respiratory
tract.

The symptoms of SARS develop over 1 week and start
with a fever. Early on, people develop flu-like symptoms,
such as:
a dry cough
chills
diarrhea
breathlessness
aches
Pneumonia, a severe lung infection, usually develops. At
its most advanced stage, SARS causes failure of the lungs,
heart, or liver.
According to the CDC, authorities reported that 8,098
people contracted SARS during the outbreak. Among these
people, 774 died of the disease. This indicates a mortality
rate of 9.6%.
Complications are more common among older adults.
According to one source, more than half of those who died
from the infection were over the age of 65. Authorities
eventually controlled SARS in July 2003.

MERS
MERS is caused by the MERS-CoV coronavirus.
Scientists first recognized this severe respiratory illness in
2012 after it surfaced in Saudi Arabia. Since then, it has
spread to other countries.
The virus has reached the U.S. However, only two
people in the country have tested positive for MERS-CoV,
and this was in 2014. As a result, the CDC state that the
risk of developing MERS in the U.S. is very low.Symptoms
of MERS include a fever, breathlessness, and coughing
The illness spreads through close contact with people who
have the infection.
A 2019 investigation into MERS found that the disease
is fatal in 35.2% of people who develop it.

HOW CAN IT BE DETECTED?
The virus can be detected using a RT-PCR test . An RT-
PCR or reverse transcription polymerase chain reaction
test is DNA-based and can quickly tell if someone
harbours the virus.
In India, the government facilities to test for the virus
include 52 labs belonging to the Viral Research and
Diagnostic Laboratories network of the Indian Council of
Medical Research (ICMR), 10 labs under the National
Centre for Disease Control (NCDC), and the NIV.

WHAT IS THE TREATMENT?
There is no current evidence from randomised
controlled trial to recommend any specific treatment for
suspected or confirmed COVID19 patients.
No specific anti-virals are recommended for treatment
of those suffering from respiratory ailment due to lack of
adequate evidence from medical literature.

In India, the Union Health Ministry guidelines has
recommended use of anti-HIV drug combinations Lopinavir
and Ritonavir on a case-tocase basis depending upon the
severity of the condition of a person having coronavirus
infection.
The Ministry recommended Lopinavir-Ritonavir for high-
risk groups: patients aged above 60, suffering from
diabetes mellitus, renal failure, chronic lung disease and are
immuno-compromised. However, the use of Lopinavir-
Ritonavir in PEP regimens for HIV is also associated with
significant adverse events which many times leads to
discontinuation of therapy.
The guidelines advise the treating doctors to closely monitor
patients with severe acute respiratory infection for signs of
clinical deterioration, such as rapidly progressive respiratory
failure and sepsis, and apply supportive care interventions
immediately. “Application of timely, effective, and safe
supportive therapies is the cornerstone of therapy for patients
that develop severe manifestations of COVID-19,” it said.

CAN A VACCINE BE DEVELOPED FOR COVID-19?
According to Raman. R. Gangakhedkar, head of the
Epidemiology and Communicable Diseases-I (ECD-I),
Division of ICMR, there are two ways of going for vaccine
preparation — either you look at the sequences of the
gene which then may lead to development of antibodies,
or you actually have the strain and then you try to
develop a vaccine which is always an easier option.
He said Indian scientists have managed to successfully
isolate the COVID-19 virus and about 11 isolates are
available which is a prime requisite for doing any kind of
research related to viruses and developing the vaccine.
Internationally, several institutes and pharmaceutical
companies are in various stages of developing the vaccine
with some set to go on clinical trials soon.

PROTECTING YOURSELF AGAINST COVID-19
Guidelines by the World Health Organization specify that one
of the ways to reduce the risk of infection is by regularly and
thoroughly cleaning one’s hands with an alcohol-based hand
rub or washing them with soap and water.
Regular washing becomes important as the virus tends to be
viable from hours to more than a day on different surfaces that
are regularly touched with hands.
WASHING WITH SOAP
The grime on our hands contains innumerable viruses and
bacteria.
Washing with water without using soap helps reduce the
amount of microbes but does not remove most of the virus and
bacteria completely. Using soap, therefore, becomes far more
effective in removing microbes.

Viruses such as coronavirus, influenza-causing viruses,
Ebola, Zika have their genetic material encased in a layer
of fat called the lipid envelope8 .
Soap molecules are pin-shaped with a head that is
waterloving (hydrophilic) and a tail that is oil-loving
(oleophilic). Being oleophilic, the tail portion of the
molecule tends to have an affinity for and ‘competes’ with
the lipids in the virus envelope.
Since the chemical bonds holding the virus together are
not very strong, the long oleophilic tail gets inserted into
the envelope and tends to have a ‘crowbar’ effect that
breaks the lipid envelope of the virus.
The tail also competes with the bond that binds the RNA
and the lipid envelop thus dissolving the virus into its
components which are then removed by water.

ALCOHOL-BASED HAND SANITISERS
Like soap, the alcohol present in hand sanitisers
dissolve the lipid envelope, thus inactivating the virus. In
addition, the alcohol also tends to change the shape or
denature the mushroom-shaped protein structures that
stick out of the lipid envelope.
The mushroom-shaped protein structures help the virus
to bind to special structures found on human cells and
enter the cells. To be effective, the sanitisers should
contain at least 60% alcohol. Unlike soap lather, the
alcohol does not come in contact with all parts of the
hand.

So care needs to be taken to use sufficient sanitiser to
increase the coverage. Unlike water, alcohol run does not
remove the dead viruses from the hand. While a sanitiser
can quickly reduce the number of microbes, it does not
get rid of all types of germs, and is “not as effective when
hands are visibly dirty or greasy”.

USING A MASK
Medical masks help prevent the spread of coronavirus
infection. If worn properly, masks may be effective in
preventing transmission of coronavirus. An article
published in the Journal of the American Medical
Association (JAMA) says there is no evidence to suggest
that masks worn by healthy individuals can help prevent
infection.
But a 2010 study says: “Mask wearing was associated
with reduced secondary transmission and should be
encouraged during outbreak situations.” Even the World
Health Organization says wearing a medical mask is “one
of the prevention measures to limit spread of certain
respiratory diseases, including novel coronavirus (SARS-
CoV-2), in affected areas”. Transmission through droplets
from coughing and sneezing is one of the major routes of
virus spread. When worn correctly, a mask can reduce
the risk of inhaling droplets containing the virus.

With many studies showing that people infected with
novel coronavirus transmit the virus even before
symptoms show up, it may be prudent to wear a mask
especially when the virus is spreading in the community.
In a country like India, maintaining at least one metre
distance can be a challenge, especially when there is no
way of knowing who is infected till such time the person
starts showing visible symptoms.

SOCIAL DISTANCING
The WHO says that you should maintain at least 1
metre (3 feet) distance between yourself and anyone who
is coughing or sneezing. This is because when someone
coughs or sneezes they spray small liquid droplets from
their nose or mouth which may contain virus. “If you are
too close, you can breathe in the droplets, including the
COVID-19 virus if the person coughing has the disease,”
says the WHO.
1METER
3 FEET

AVOID TOUCHING EYES, NOSE AND MOUTH
Hands can pick up viruses as they come in contact with
many surfaces.
It can then transfer the virus to your eyes, nose or
mouth. From there, the virus can enter your body and
can make you sick.

PRACTISE RESPIRATORY HYGIENE
Cover your mouth and nose with your bent elbow or
tissue when you cough or sneeze.
Then dispose of the used tissue immediately.

CORONA VIRUS

More Related Content

What's hot

Similar to CORONA VIRUS

More from Jai Narain Vyas University Jodhpur Rajasthan India 342003

Recently uploaded

CORONA VIRUS